Navigation Links
Global Hyaluronic Acid Market to Grow to $2.5 Billion by 2017
Date:1/28/2013

TORONTO, Jan. 28, 2013 /PRNewswire/ -- According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, the patient pool for hyaluronic acid (HA) viscosupplementation will continue to expand globally, due to rising rates of osteoarthritis and obesity, leading to moderate growth in the global HA viscosupplementation market to nearly $2.5 billion by 2017.

(Logo: http://photos.prnewswire.com/prnh/20130103/MM36799LOGO )

The most significant treatment trend will continue to be the shift to premium-priced shorter treatment regimens, which offer more convenience for the patient and increase patient compliance with treatment. This trend will occur worldwide. While 5-injection treatments are still the leading choice for patients globally, the number is skewed by Japan, where more than 80 percent of such procedures were performed in 2011. One- and 3-injection treatments will continue to rise as a proportion of total treatments.

While HA viscosupplementation treatments are used primarily in the knee, there will be a shift toward using this treatment for other joints in the body, as physicians become more comfortable performing the procedure on non-knee areas. Manufacturers are investing in non-knee clinical trials to provide support for this shift.

"Despite the diverse competitive landscape for these products, two companies have captured over half the global market," said MRG Analyst Kristina Vidug . "While they both sell in all three major regions, Seikagu is strongest in Asia Pacific, while Sanofi dominates the United States market."

Companies that compete on price, introduce a product that is specific to a non-knee indication or release a single-injection product will be most successful in thi
'/>"/>

SOURCE Millennium Research Group
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Health Diagnostic Laboratory, Inc. and Global Genomics Group join forces to form a new scientific process
2. Point of Care Testing Market and Forecast to 2016: Global Analysis
3. Medical Specialty Bags Market - Global Industry Size, Market Share, Trends, Analysis And Forecast, 2012 - 2018
4. Global Brachytherapy Devices Market 2012-2016
5. Global DNA Sequencing Products Market 2012-2016
6. Breakthrough Research Could Create Sea Change in Global HIV Diagnosis: New Handheld Mobile Device Performs Laboratory-Quality HIV Testing
7. Life Science Veterans Highlight Opportunities at BIOCOM 3rd Annual Global Partnering Conference
8. Global Medical Device Marketing Groups Respond to Internal Cost Pressures
9. Pharmaceuticals: Global Industry Guide
10. Global Biosimilars: A return to optimism?
11. Global Bariatric (Obesity) Surgical Devices Industry
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2015)... , May 21, 2015  AbbVie (NYSE: ... amounts pursuant to its previously announced offer to acquire ... ("Pharmacyclics") for a mix of cash and AbbVie common ... S-4 filed with the Securities and Exchange Commission by ... the assumption that the exchange offer will expire at ...
(Date:5/21/2015)... May 21, 2015 Delcath Systems, Inc. (NASDAQ: ... study cohort of its expanded Global Phase 2 Clinical ... of  patients with unresectable hepatocellular carcinoma (primary liver cancer, ... study will be conducted at the same hospitals in ... Phase 2 HCC trial, and ICC enrollment is now ...
(Date:5/21/2015)... , May 21, 2015 Dipexium ... stage pharmaceutical company focused on the development and ... research collaborators, today announced a scientific poster presentation ... 3 pivotal trials evaluating Locilex®, its novel, broad ... patients with mild infections of diabetic foot ulcers ...
Breaking Medicine Technology:AbbVie Announces Offer Consideration for Acquisition of Pharmacyclics 2AbbVie Announces Offer Consideration for Acquisition of Pharmacyclics 3AbbVie Announces Offer Consideration for Acquisition of Pharmacyclics 4ICC Cohort Of Delcath's Global Phase 2 Trial Of Melphalan/HDS In Hepatocellular Carcinoma Now Open For Enrollment 2ICC Cohort Of Delcath's Global Phase 2 Trial Of Melphalan/HDS In Hepatocellular Carcinoma Now Open For Enrollment 3ICC Cohort Of Delcath's Global Phase 2 Trial Of Melphalan/HDS In Hepatocellular Carcinoma Now Open For Enrollment 4Dipexium Announces Presentation at 7th International Symposium on the Diabetic Foot 2Dipexium Announces Presentation at 7th International Symposium on the Diabetic Foot 3Dipexium Announces Presentation at 7th International Symposium on the Diabetic Foot 4Dipexium Announces Presentation at 7th International Symposium on the Diabetic Foot 5
... reached listeners in nine,cities across the United States, ... Adams,Morning Show and nine Radio One gospel radio ... Radiothon on Thursday, April 3,2008, benefiting St. Jude ... United States, the national fundraiser helped raise,awareness for ...
... be Presented at European Association for the Study of the ... Liver Annual ... that it has completed its Phase 2 study of its lead,compound, MitoQ(R) ... The European Association for the Study of the Liver,(EASL) Annual Meeting, being ...
Cached Medicine Technology:The Yolanda Adams Morning Show and Radio One Gospel Stations Raise More Than $1 Million During National Radiothon Benefiting St. Jude 2The Yolanda Adams Morning Show and Radio One Gospel Stations Raise More Than $1 Million During National Radiothon Benefiting St. Jude 3Antipodean Pharmaceuticals Announces Completion of Phase 2 Study of Lead Compound MitoQ(R) 2
(Date:5/22/2015)... 22, 2015 Steven Winter Associates (SWA) ... has been selected by Consulting-Specifying Engineer (CSE) magazine as ... are featured in the May/June issue of the publication. ... professionals age 40 and younger who have, and continue ... well as in other areas of their professional and ...
(Date:5/22/2015)... Portland, Maine (PRWEB) May 22, 2015 ... in single-use swabs for the medical, diagnostic, environmental, ... their entire line of products in the US. ... moving their operations outside the US, Puritan remains ... of products at their Guilford, Maine facility. , ...
(Date:5/22/2015)... Orlando, FL (PRWEB) May 22, 2015 ... United States and developmental projects in rural India. India ... most popular community projects that continues to help hundreds ... is pleased to sponsor a music concert by famous ... fundraise for the Hindu Society of Central Florida ...
(Date:5/21/2015)... The Johns Hopkins Alliance for Science ... Commercial Advisory Board has selected a research project at ... one of two $50,000 Abell Foundation Award for Excellence ... as Anklebot. Developed by the VA Maryland Exercise ... University of Maryland School of Medicine and Massachusetts Institute ...
(Date:5/21/2015)... York, New York (PRWEB) May 21, 2015 ... The Atmananda Yoga Studio and Sequence, is excited ... Atmananda Yoga Mat™, which was previously available for use ... Atmananda Yoga Mat™ unique is that it's mathematically ... prevent serious joint injuries and muscle strains, commonly ...
Breaking Medicine News(10 mins):Health News:Steven Winter Associates’ Marc Zuluaga Earns Innovative Engineering Award 2Health News:Maine Swab Company Celebrates 96 Years of American-made Products 2Health News:India Network Visitor Health Insurance Announces Corporate Sponsorship of Anuradha Paudwal Musical in Orlando to Help Fundraise for Hindu Society of Central Florida. 2Health News:VA Maryland Health Care System Researchers Selected for Abell Foundation Innovation Award 2Health News:VA Maryland Health Care System Researchers Selected for Abell Foundation Innovation Award 3Health News:NY's Atmananda Yoga Studio Launches Its Patented "Alignment" Yoga Mat for Public Sale 2
... threatened to mobilise US congressmen and senators against Indian authorities ... Act in a case relating to his crusade against the ... wife died of alleged wrongful treatment in India in May ... and congressmen in US and will ask them to raise ...
... scientists has revealed a startling find. Around 75 percent of ... to the risks of developing heart diseases. And thats ... that is connected with diabetes. ,The findings, made by ... people have heart disease even if they do not have clear ...
... warned the consumer against the multiple sites that sell counterfeit ... learned about the 24 related web sites that were involved ... counterfeit versions of Xenical 120 mg capsules was sold from ... help obese people lose weight and maintain it. The capsules ...
... babies with lethal and disabling conditions is illegal worldwide, but ... countries. ,An editorial in this weeks BMJ ... about 200,000 live births occur annually; of these, 10-20 babies ... be actively killed. Yet between 1997 and 2004 only 22 ...
... NIH's National Eye Institute is seeking to raise glaucoma awareness ... disease than others, the Casa Grande Valley Dispatch reports. ... and people with a family history of glaucoma all face ... have primary open-angle glaucoma, the most common form glaucoma. ...
... Sociology, author Alison Howell traces the psychological pathologization of ... resisters of the detainment accredit the attempted suicides to ... ,As the high prevalence of suicide attempts at the ... two major responses have emerged: the United States military ...
Cached Medicine News:Health News:NRI Threatens to Move US Congress for Justice in India 2Health News:Gene Mutations Leave Caucasians Prone To Heart Diseases And Diabetes 2Health News:Should the UK Adopt Dutch Rules on Euthanasia in Newborn Babies? 2Health News:Study Examines the Pathologization of Guantanamo Suicides 2
30 Degree angle....
Leica M500 MS3 robotic stand for neuro, spine surgery and ENT. Motorized XY-movement for precise positioning of the optical axis in eight directions, inclination and tilt....
Advanced operating microscope with high-resolution apochromatic optics. Senso-servo drive to keep the microscope in perfect balance even if parts are moved or mounted elsewhere....
Advanced operating microscope with zoom and variable focus up to 500 mm....
Medicine Products: